Company Directory / Biotechnology Research
Public · NASDAQ:GBTFor profitBiotechnology ResearchSouth San Francisco, California, United States
Global Blood Therapeutics
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
- Founded
- 2011 15 years ago
- Staff
- 251-500 85 on LinkedIn
- Followers
- 23k on LinkedIn
- Funding
- $970M as listed, USD
Global Blood Therapeutics (GBT) is now part of Pfizer, and we look forward to continuing our mission on behalf of people living with sickle cell disease. The Global Blood Therapeutics page will no longer be active or monitored. Please follow Pfizer for new content.
Set against six million companies
Size
251-500 people: larger than 92% of companies with a size listed. 85 people list it on LinkedIn.
Age
15 years old.
Reach
Website ranked #10,501,589 in the world for traffic, about 226 visits a month. 22,570 followers on LinkedIn.
What it does
BiotechnologyGeneticsMedicalTherapeutics
Funding, as listed
$970M raised in total
- Rounds7
- LatestPost ipo debt, Dec 2021
- Latest amountUSD 300,000,000
- Investors6, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Global Blood Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Global Blood Therapeutics
- Type
- For profit
- Status
- Public · NASDAQ:GBT
- Founded
- 2011
- Founders
- Andrej Sali, Charles Homcy, Craig Muir, David Phillips, Jack Taunton, Matthew Jacobson
- Industry
- Biotechnology Research
- Categories
- Biotechnology, Genetics, Medical, Therapeutics
Where
- City
- South San Francisco
- Region
- California
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 251-500
- People on LinkedIn
- 85
- LinkedIn followers
- 22,570
- Web traffic rank
- #10,501,589
- Monthly web visits
- 226
Funding, as listed
- Total
- $969,500,000 USD
- Rounds
- 7
- Latest round
- Post ipo debt
- Latest round date
- Dec 2021
- Latest amount
- 300,000,000 USD
- Investors
- 6
- Lead investors
- 1
- Stock listing
- NASDAQ:GBT
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Companies like it
Biotechnology Research in United States.
Editas MedicineCambridge · 251-500 people · 49k followers
Cogent BiosciencesWaltham · 101-250 people · 13k followers
CueSan Diego · 1001-5000 people · 23k followers
Recursion PharmaceuticalsSalt Lake City · 501-1000 people · 65k followers
Apeel SciencesGoleta · 101-250 people · 37k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.